VCNX - Vaccinex reports Q1 results May, 15 2019 08:12 AM Vaccinex Inc. Vaccinex (NASDAQ:VCNX): Q1 Revenue of $0.09M (-55.0% Y/Y)Cash and cash equivalents and marketable securities of $11.3M.Press ReleaseMore news on: Vaccinex, Inc., Earnings news and commentary, Healthcare stocks news, ,